Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 14 studies | 27% ± 11% | |
| oligodendrocyte | 9 studies | 32% ± 12% | |
| glutamatergic neuron | 8 studies | 44% ± 27% | |
| ciliated cell | 8 studies | 29% ± 11% | |
| fibroblast | 8 studies | 21% ± 6% | |
| astrocyte | 7 studies | 33% ± 17% | |
| macrophage | 6 studies | 30% ± 5% | |
| GABAergic neuron | 6 studies | 47% ± 23% | |
| oligodendrocyte precursor cell | 6 studies | 27% ± 10% | |
| microglial cell | 5 studies | 25% ± 4% | |
| epithelial cell | 5 studies | 24% ± 4% | |
| type II pneumocyte | 5 studies | 19% ± 4% | |
| plasma cell | 4 studies | 26% ± 9% | |
| endothelial cell of lymphatic vessel | 4 studies | 26% ± 2% | |
| interneuron | 4 studies | 50% ± 24% | |
| neuron | 3 studies | 30% ± 14% | |
| retinal rod cell | 3 studies | 19% ± 4% | |
| type I pneumocyte | 3 studies | 23% ± 4% | |
| goblet cell | 3 studies | 26% ± 11% | |
| adipocyte | 3 studies | 20% ± 3% | |
| mast cell | 3 studies | 17% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 553.41 | 1444 / 1445 | 100% | 6.72 | 183 / 183 |
| lung | 100% | 734.39 | 578 / 578 | 99% | 6.44 | 1147 / 1155 |
| stomach | 100% | 590.85 | 359 / 359 | 99% | 7.63 | 282 / 286 |
| intestine | 100% | 699.17 | 966 / 966 | 98% | 8.58 | 519 / 527 |
| pancreas | 100% | 526.86 | 327 / 328 | 98% | 6.36 | 175 / 178 |
| brain | 99% | 408.39 | 2627 / 2642 | 98% | 4.88 | 690 / 705 |
| breast | 100% | 755.64 | 459 / 459 | 97% | 6.46 | 1080 / 1118 |
| prostate | 100% | 582.67 | 245 / 245 | 96% | 7.88 | 484 / 502 |
| kidney | 100% | 861.78 | 89 / 89 | 95% | 7.96 | 860 / 901 |
| skin | 100% | 749.30 | 1808 / 1809 | 95% | 7.76 | 450 / 472 |
| bladder | 100% | 588.62 | 21 / 21 | 95% | 6.37 | 478 / 504 |
| thymus | 100% | 808.87 | 653 / 653 | 93% | 5.59 | 565 / 605 |
| uterus | 100% | 711.06 | 170 / 170 | 92% | 5.19 | 422 / 459 |
| liver | 100% | 679.62 | 225 / 226 | 90% | 5.76 | 366 / 406 |
| adrenal gland | 100% | 1159.72 | 258 / 258 | 85% | 5.12 | 196 / 230 |
| ovary | 100% | 684.85 | 180 / 180 | 65% | 2.21 | 279 / 430 |
| adipose | 100% | 753.93 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 596.03 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 606.01 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 438.94 | 797 / 803 | 0% | 0 | 0 / 0 |
| heart | 94% | 533.53 | 810 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 4.95 | 42 / 45 |
| peripheral blood | 86% | 433.90 | 795 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 3.87 | 24 / 29 |
| eye | 0% | 0 | 0 / 0 | 70% | 2.80 | 56 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005975 | Biological process | carbohydrate metabolic process |
| GO_0046835 | Biological process | carbohydrate phosphorylation |
| GO_0006012 | Biological process | galactose metabolic process |
| GO_0005829 | Cellular component | cytosol |
| GO_0004335 | Molecular function | galactokinase activity |
| GO_0033858 | Molecular function | N-acetylgalactosamine kinase activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | GALK2 |
| Protein name | N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2) Galactokinase 2 (cDNA, FLJ79339, highly similar to N-acetylgalactosamine kinase) Galactokinase 2 |
| Synonyms | GK2 |
| Description | FUNCTION: Acts on GalNAc. Also acts as a galactokinase when galactose is present at high concentrations. May be involved in a salvage pathway for the reutilization of free GalNAc derived from the degradation of complex carbohydrates. . |
| Accessions | H0YLF9 ENST00000558145.5 H0YN31 ENST00000559963.5 ENST00000558956.5 H0YLL8 ENST00000559883.5 ENST00000544523.5 ENST00000327171.7 [Q01415-2] H0YNR7 ENST00000561074.5 ENST00000560031.6 [Q01415-1] H0YK30 H0YML1 H0YND3 ENST00000560654.5 ENST00000559423.5 ENST00000558775.5 H0YLL3 ENST00000560528.1 ENST00000559208.5 ENST00000560119.5 H0YK10 ENST00000560138.5 ENST00000559454.5 H0YLK3 ENST00000559580.5 H0YN87 ENST00000396509.6 ENST00000558399.5 H0YM44 B7ZAX5 Q01415 |